跳至主要内容
临床试验/CTRI/2019/03/017914
CTRI/2019/03/017914进行中(未招募)不适用

International Diabetes Management Practice Study

Sanofi India Limited25 个研究点 分布在 1 个国家目标入组 270 人开始时间: 2019年6月3日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
270
试验地点
25
主要终点
The global proportion of patients with T2DM treated with insulin

研究概览

简要总结

IDMPS is a yearly international,multicenter, non-interventional, observational study to assess currentpractices in the management of care of patients with type 1 and type 2 diabetesmellitus (T1DM and T2DM). Wave 8 of IDMPS is composed of a cross-sectional surveyof 2 weeks’ duration and of a longitudinal 9-month follow-up period. In

this study, eachphysician will enter the first 10 patients with T2DM visiting him/her withinthe 2-week study period, and the first 5 patients with T1DM visiting him/her inthis timeframe. The patients will then be kept in the study for a 9-monthfollow-up period

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • Cross sectional phase.
  • All male and female adults (with lower legal age limitations (country specific) diagnosed with type 1 or type 2 diabetes, visiting the physician during the recruitment period of the cross-sectional study, up to the number of patients allocated to the physician.
  • Written informed consent
  • Longitudinal phase.
  • Each patient will be asked to enter into the 9-month follow-up period.

排除标准

  • Cross sectional phase.
  • Concomitant participation in a clinical trial.
  • Current temporary insulin therapy (eg, gestational diabetes, surgery, pancreas cancer)
  • Longitudinal phase.
  • Concomitant participation in clinical trial.

结局指标

主要结局

The global proportion of patients with T2DM treated with insulin

时间窗: 9 months

次要结局

  • The management of care of patients with type 2 diabetes (T2DM) (CS) will be illustrated(by:)

研究者

申办方类型
Pharmaceutical industry-Global

研究点 (25)

Loading locations...

相似试验